Pioglitazone-d4

• Description :

  Pioglitazone-d4 is a deuterium labeled Pioglitazone. Pioglitazone (U 72107) is a potent and selective PPARγ agonist with high affinity binding to the PPARγ ligand-binding domain with EC50 of 0.93 and 0.99 μM for human and mouse PPARγ, respectively[1].

• Product Name Alternative :

  U 72107-d4

• UNSPSC :

  12352005

• Target :

  Ferroptosis; PPAR

• Type :

  Isotope-Labeled Compounds

• Related Pathways :

  Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor

• Applications :

  Metabolism-protein/nucleotide metabolism

• Field of Research :

  Cancer; Metabolic Disease

• Purity :

  99.34

• Solubility :

  10 mM in DMSO|DMF : ≥ 2.5mg/mL|DMSO : ≥ 2.5mg/mL

• Smiles :

  O=C(N1)SC(CC2=C([2H])C([2H])=C(OCCC3=NC=C(CC)C=C3)C([2H])=C2[2H])C1=O

• Molecular Formula :

  C19H16D4N2O3S

• Molecular Weight :

  360.46

• References & Citations :

  [1]Kuwabara K, et al. A novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-c-5-[4-[5-methyl-2- (4-methylphenyl) -4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), potently decreases plasma triglyceride and glucose leve

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C, 3 years (Powder)

• Scientific Category :

  Isotope-Labeled Compounds

• Clinical Information :

  Launched

• CAS Number :

  [1134163-29-3]